ConditionsIgf 1 Deficiency

Igf 1 Deficiency

IGF-1 deficiency is a condition marked by the body's inadequate production or release of insulin-like growth factor 1 (IGF-1). This deficiency can lead to several symptoms, with the most notable being an impediment in tissue and skeletal growth, often resulting in shorter than average height.

Best medications for Igf 1 Deficiency

coupons from$15255.79Save 72%

Best medications for Igf 1 Deficiency

Increlex Save 72%coupons from $15255.79

Causes

The development of IGF-1 deficiency can stem from various genetic and physiological factors:

  • Genetic Mutations: Conditions like Laron syndrome involve genetic mutations that can impair the growth hormone receptors. When these receptors do not function correctly, the release and activity of IGF-1 are hindered, affecting growth and development.

  • Growth Hormone Resistance: Even with normal growth hormone levels, the body may sometimes resist the hormone, leading to low IGF-1 levels and resulting in growth deficiencies. This resistance interferes with the hormone's role in promoting healthy tissue and bone growth.

  • Liver Dysfunction: The liver, as the main site for IGF-1 production in response to growth hormone, plays a critical role. Any dysfunction in the liver can significantly decrease IGF-1 levels, crucial for normal physiological growth.

Symptoms

IGF-1 deficiency manifests through various symptoms, predominantly affecting growth patterns:

  • Children with IGF-1 deficiency may have a shorter stature, making them appear younger than their peers. It's important to note that this does not impact their intellectual abilities.

  • Affected children might also show signs of fatigue and general lack of energy, impacting daily activities.

  • Notably, in this condition, growth hormone levels are typically normal, but due to low IGF-1 levels, the body cannot effectively use the growth hormones, which are crucial for growth processes.

Diagnosis

Diagnosing IGF-1 deficiency requires both clinical assessments and biochemical tests. Physicians look for signs like stunted growth or short stature, ensuring that growth hormone levels are within normal ranges. A crucial diagnostic step is a blood test to measure IGF-1 levels, with low levels indicating deficiency. It's vital to rule out other causes of poor growth, such as chronic illness or poor nutrition. In severe cases where IGF-1 levels are very low, genetic testing may be conducted to identify any genetic anomalies affecting the growth hormone-IGF-1 pathway. Early and accurate diagnosis is essential to provide timely treatment and support.

Treatments

Treatment of IGF-1 deficiency, particularly in severe cases, often involves the medication mecasermin. Mecasermin, a synthetic version of IGF-1, helps children who exhibit IGF-1 deficiency despite normal growth hormone levels. By directly increasing IGF-1 levels, it supports growth, improves bone density, and allows children with Primary IGF-1 Deficiency to achieve a normal growth rate. The medication is administered via injections under the skin, usually twice daily with meals, due to its impact on blood sugar levels. This treatment is intended for children meeting specific age and health criteria.

Medications

  • Mecasermin is prescribed to manage IGF-1 deficiency, particularly when there's no accompanying growth hormone deficiency. This synthetic IGF-1 aids in supplementing the body's deficiency, crucial for facilitating growth in children with low natural IGF-1 levels.

  • Administered by injection under the skin, mecasermin should ideally be given immediately before or shortly after a meal for optimal effectiveness.

  • Patients or their caregivers must learn correct preparation and injection techniques to administer the medication safely at home. Proper training ensures safety and effective treatment.

  • Regular healthcare provider visits are crucial for monitoring, ensuring the dosage remains appropriate and observing any side effects or developments in growth patterns.

Prevention

  • IGF-1 deficiency largely stems from genetic mutations affecting the growth hormone pathway, and currently, no specific prevention measures exist due to its genetic nature.

  • While genetic factors are non-preventable, early diagnosis and intervention significantly help in managing symptoms effectively.

  • Families with a history of IGF-1 deficiency are advised to consider genetic counseling to evaluate their risk when planning children. Genetic testing may also be helpful if there's a familial history or suspicion of the deficiency.

  • Monitoring growth in children and discussing any concerns with a healthcare provider allows for timely management and intervention with hormone therapies, supporting growth-related challenges associated with IGF-1 deficiency.